Hello!
To view this content, please sign up or log in – it’s free and easy! Stay ahead with curated regulatory insights designed for professionals like you.
"On "15/11/2024", the "European Medicines Agency (EMA)" issued an update regarding "Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 November 2024". The CHMP recommended eight new medicines for approval, including Augtyro for advanced solid tumours and Gohibic for SARS-CoV2-induced acute respiratory distress syndrome.
Hello!
To view this content, please sign up or log in – it’s free and easy! Stay ahead with curated regulatory insights designed for professionals like you.
Highlights content goes here...
Hello!
To view this content, please sign up or log in – it’s free and easy! Stay ahead with curated regulatory insights designed for professionals like you.
An OTP has been sent to your registered email address.